Having women in leadership roles isn’t just good for business – it’s good for patients too by Hannah Adler April 11, 2024April 11, 2024 Gender equality is an ongoing priority for all sectors, and one that has been increasingly discussed […]
Medical bodies claim medicinal cannabis telehealth services are under-regulated and some put profits before patients by Stu Finlayson April 9, 2024April 9, 2024
Local firms call for united voice to tackle import-export disparity as Australia is branded a cannabis ‘honeypot’ by Steve Jones March 27, 2024March 27, 2024
Launch of consumer strategy ‘not taken lightly’, as ECS Botanics looks to capitalise on ‘unique IP’ by Steve Jones March 11, 2024March 11, 2024
German legalisation set to ‘open up opportunities’ for Australian firms by Steve Jones February 29, 2024February 29, 2024
Company news: Zelira; ECS Botanics; LGP; Ecofibre; Neurotech; Elixinol; Emyria by Steve Jones and Martin Lane February 28, 2024February 29, 2024
ECS Botanics chases in-house product growth after A$4m capital raise by Steve Jones February 22, 2024February 22, 2024
ECS strikes another offtake agreement, bringing total to $60m in 18 months by Martin Lane February 1, 2024February 1, 2024
ECS Botanics boosts product range along with MD’s salary by Martin Lane November 13, 2023November 13, 2023
ECS Botanics records another cashflow positive quarter by Martin Lane October 16, 2023October 16, 2023